Christopher Robinson/LinkedIn
Jul 4, 2026, 07:43
Christopher Robinson: Nipocalimab Phase 3 Trials in Fetal and Neonatal Alloimmune Thrombocytopenia
Christopher Robinson, Associate Professor Maternal Fetal Medicine at University of South Carolina, shared a post on LinkedIn:
“Design of the Phase 3 FREESIA-1 and FREESIA-3 Trials of Nipocalimab in Fetal and Neonatal Alloimmune Thrombocytopenia – Development of FNAIT․”
Title: Plain Language Summary of Publication: Design of the Phase 3 FREESIA-1 and FREESIA-3 Trials of Nipocalimab in Fetal and Neonatal Alloimmune Thrombocytopenia
Authors: Pamela Baker, Babajide Keshinro, Barbara Stegmann, Abbie Oey, Cathye Shu, Dirk Heerwegh, Rebecca Zaha, Hillary Van Valkenburgh
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 5, 2026, 17:08The Opening Ceremony Has Started With the ESHRE Chair Anis Feki’s Welcome – ESHRE SIG Fertility Preservation
-
Jul 5, 2026, 17:04Every Parent Wants the Best Start for Their Baby – WHO
-
Jul 5, 2026, 16:53Eve Feinberg: Looking Forward to Recording Fertility and Sterility On Air at ESHRE 2026
-
Jul 5, 2026, 16:42Nataly Atalla: Best Education and Latest Updates Led by Cristina Hickman at ESHRE London 2026
-
Jul 5, 2026, 16:36Christopher Robinson: The Role of Professional Obligations for Cesarean Delivery on Maternal Request
-
Jul 5, 2026, 16:30Does Endometrial Scratching Improve IVF Success? – Fertility Plus
-
Jul 5, 2026, 16:24Downloadable Conference Highlights Feature RBMO Editors at ESHRE 2026 – RBMO
-
Jul 5, 2026, 15:37Don’t Miss Tomorrow’s Keynote Session! – ESHRE
-
Jul 5, 2026, 15:29Ying Cheong: Another Thought-Provoking Session at the ESHRE 2026 By Kirsten Tryde Macklon